Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
Authors
Lena Hafrén (ORCID: https://orcid.org/0000-0002-4968-4357)
Anu Laulajainen‐Hongisto (ORCID: https://orcid.org/0000-0001-5109-6944)
Paula Virkkula (ORCID: https://orcid.org/0000-0003-4224-5201)
Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
Lena Hafrén, Anu Laulajainen‐Hongisto, Paula Virkkula, Tanzeela Hanif et al.
Citations
2 citations
Journal
Frontiers in Allergy
Topics
Sinusitis and nasal conditions
Field-Weighted Citation Impact (FWCI)
3.70
article
Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
Lena Hafrén, Anu Laulajainen‐Hongisto, Paula Virkkula, Tanzeela Hanif, Alma Helevä, Mika J. Mäkelä, Annina Lyly, Mikko Niemi, Paula Kauppi, Mikko Nuutinen, Michael Kilpiö, Sanna Toppila‐Salmi, Viljami Salmi
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in AllergyVol. 6
Institutions
University of Helsinki (FI), University of Eastern Finland (FI), Helsinki University Hospital (FI)
Funders
Sanofi, Helsingin Yliopisto, Tampereen Tuberkuloosisäätiö, Orionin Tutkimussäätiö, Filha